CAS 59122-46-2
:Misoprostol
- (+-)-Methyl (1R,2R,3R)-3-hydroxy-2-((E)-(4RS)-4-hydroxy-4-methyl-1-octenyl)-5-oxocyclopentaneheptanoate
- (11a,13E)-(±)-11,16-Dihydroxy-16-methyl-9-oxoprost-13-en-1-oic Acid Methyl Ester
- (11alpha,13E)-(+)-11alpha,16-Dihydroxy-16-methyl-9-oxoprost-13E-en-1-oic acid methyl ester
- (±)-15-Deoxy-(16RS)-16-hydroxy-16-methyl-PGE1 Methyl Ester
- Cytotec
- Isprelor
- Misogon
- Misoprost
- Misoprostil
- Misotac
- Prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (11α,13E)-
- Sc 29333
- methyl (11alpha,13E)-11-hydroxy-16,16-dimethyl-9-oxoprost-13-en-1-oate
- methyl (11alpha,13E,16S)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate
- Weitere Synonyme anzeigen
MISOPROSTOL FOR SYSTEM SUITABILITY CRS
CAS:MISOPROSTOL FOR SYSTEM SUITABILITY CRSFormel:C22H38O5Molekulargewicht:382.5341Misoprostol
CAS:Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFormel:C22H38O5Farbe und Form:Colorless Light Yellow Liquid ViscousMolekulargewicht:382.27192Misoprostol
CAS:Misoprostol, a prostaglandin E1 derivative, has a strong inhibitory effect on gastric acid secretion, while having a contractile effect on pregnancy.Formel:C22H38O5Reinheit:99.78%Farbe und Form:Water-Soluble Viscous LiquidMolekulargewicht:382.53Misoprostol (0.10% wt/v in METHYL ACETATE), min. 97%
CAS:Formel:C22H38O5Reinheit:min. 97%Farbe und Form:White to Yellowish Oil (SOLUTION IN 10% METHYL ACETATE)Molekulargewicht:382.53Misoprostol (Mixture of Diastereomers)
CAS:Formel:C22H38O5Farbe und Form:Pale Yellow OilMolekulargewicht:382.54Misoprostol
CAS:Formel:C22H38O5Reinheit:≥ 99.0%Farbe und Form:Colourless to light yellow liquidMolekulargewicht:382.53Misoprostol
CAS:Kontrolliertes ProduktApplications Misoprostol is a cytoprotective prostaglandin PGE1 analogue.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Graham, Y., et al.: Lancet, 2, 1277 (1988); Graham, D.Y., et al.: Ann. Int. Med., 119, 257 (1993); Fletcher, H., et al.: Obstet. Gynecol., 83, 244 (1994);Formel:C22H38O5Farbe und Form:Light Yellow ViscousMolekulargewicht:382.53Misoprostol, 1% in cellulose
CAS:Kontrolliertes ProduktFormel:C22H38O5Farbe und Form:Single SolutionMolekulargewicht:382.53Misoprostol - 1% in cellulose
CAS:Kontrolliertes ProduktMisoprostol is a nonsteroidal anti-inflammatory drug that is used for the treatment of dysmenorrhea and chronic non-specific low back pain. Misoprostol is also used in nephrology dialysis to decrease blood pressure, heart rate, and fluid retention in patients with congestive heart failure. It has been shown that misoprostol can be used to prevent preterm labor in pregnant women with a statistically significant reduction in the risk of miscarriage, preterm birth, and neonatal death. It has been shown that misoprostol can be administered orally or vaginally for the prevention of preterm labor. The pharmacokinetic properties of misoprostol are dose-dependent; higher doses result in faster absorption. Clinical relevance is dependent on the concentration-time curve, which determines how quickly the drug reaches its peak concentration. The clinical relevance of misoprostol is determined by the dose group (low dose or high dose), as well as diastolicFormel:C22H38O5Reinheit:Min. 95%Farbe und Form:PowderMolekulargewicht:382.53 g/molMisoprostol
CAS:Kontrolliertes ProduktMisoprostol is a prostaglandin E1 analogue that is used for the prevention and treatment of peptic ulcers. It also has been shown to reduce the risk of gastric cancer in the general population, although this effect may be limited to patients with a history of nonsteroidal anti-inflammatory drug use. Misoprostol has been found to be more effective in women who have already given birth than in those who have not, with a statistically significant reduction in the incidence of pregnancy during long-term use. Misoprostol is metabolized by cytochrome P450 enzymes and excreted primarily through the kidneys. The drug's pharmacokinetic properties are dependent on diastolic blood pressure, body mass index, and levels of blood sampling. Intrauterine placement can also increase its efficacy as it bypasses first-pass metabolism.
Formel:C22H38O5Reinheit:Min. 95%Farbe und Form:Colorless Clear LiquidMolekulargewicht:382.53 g/molRef: 3D-FM46798
Ausgelaufenes produkt









